ClinicalTrials.Veeva

Menu

Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay

K

Karius

Status

Completed

Conditions

Infection
Neutropenia

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02912117
004-CL-01

Details and patient eligibility

About

Prospective, observational study at Stanford University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to the Final Microbiologic Diagnosis in Patients with Fever and Neutropenia.

Enrollment

57 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age
  • Are or will be admitted to Stanford University Hospital for fever and neutropenia
  • Neutropenia - an absolute neutrophil count of <500 per cubic mm
  • Documented fever or report of fever ≥38.3 or ≥38.0 on two episodes separated by at least one hour, resulting in hospitalization for febrile neutropenia

Exclusion criteria

  • Inability to understand instructions and comply with study-related procedures
  • Any condition that in the opinion of the treating physician will prevent the subject from completing the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems